Galapagos NV (GLPG):企業の財務・戦略的SWOT分析

◆英語タイトル:Galapagos NV (GLPG) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14955
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines. The company’s clinical pipeline include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn’s disease, Phase 2 and 3 trials for ulcerative colitis, and Phase II trials for multiple additional indications; GLPG1690, an autotaxin inhibitor, which is in Phase III clinical trial for the treatment of idiopathic pulmonary fibrosis; GLPG1972 that completed Phase 1b clinical trial for the treatment of osteoarthritis; and MOR106, which is in Phase II trials for atopic dermatitis patients. It conducts clinical trials for various investigational drugs. The company works in collaboration with pharma companies for its research activities. It has its presence in the Netherlands, Belgium, France and Croatia. Galapagos is headquartered in Mechelen, Belgium.

Galapagos NV Key Recent Developments

Feb 07,2019: Evotec and Galapagos collaborate for new fibrosis target
Nov 27,2018: Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis
Oct 31,2018: Galapagos kondigt start aan van PINTA Fase 2 studie met GLPG1205 bij patiënten met idiopathische pulmonaire fibrose (IPF)
Oct 24,2018: Galapagos and AbbVie restructure CF collaboration
Oct 24,2018: Hallmark third quarter 2018 and Annual R&D update at Galapagos

This comprehensive SWOT profile of Galapagos NV provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Galapagos NV including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Galapagos NV – Key Information
Galapagos NV – Overview
Galapagos NV – Key Employees
Galapagos NV – Key Employee Biographies
Galapagos NV – Key Operational Heads
Galapagos NV – Major Products and Services
Galapagos NV – History
Galapagos NV – Company Statement
Galapagos NV – Locations And Subsidiaries
Galapagos NV – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Galapagos NV – Business Description
Galapagos NV – Corporate Strategy
Galapagos NV – SWOT Analysis
SWOT Analysis – Overview
Galapagos NV – Strengths
Galapagos NV – Weaknesses
Galapagos NV – Opportunities
Galapagos NV – Threats
Galapagos NV – Key Competitors

Section 3 – Company Financial Performance Charts

Galapagos NV – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Galapagos NV, Key Information
Galapagos NV, Key Ratios
Galapagos NV, Share Data
Galapagos NV, Major Products and Services
Galapagos NV, History
Galapagos NV, Key Employees
Galapagos NV, Key Employee Biographies
Galapagos NV, Key Operational Heads
Galapagos NV, Other Locations
Galapagos NV, Subsidiaries
Galapagos NV, Key Manufacturing facilities
Galapagos NV, Key Competitors
Galapagos NV, SWOT Analysis
Galapagos NV, Ratios based on current share price
Galapagos NV, Annual Ratios
Galapagos NV, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Galapagos NV, Performance Chart
Galapagos NV, Ratio Charts

★海外企業調査レポート[Galapagos NV (GLPG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caixa Geral de Depositos SA:企業の戦略的SWOT分析
    Caixa Geral de Depositos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • SkinMedica Inc-製薬・医療分野:企業M&A・提携分析
    Summary SkinMedica Inc (SkinMedica) is a manufacturer and distributor of skin care products. The company’s products include purifying foaming wash, facial cleanser, skin polisher, purifying toner, TNS recovery complex, uplifting eye serum, restorative ointment, dermal repair cream, and post procedur …
  • CASIO COMPUTER CO., LTD.:企業の戦略・SWOT・財務情報
    CASIO COMPUTER CO., LTD. - Strategy, SWOT and Corporate Finance Report Summary CASIO COMPUTER CO., LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • NaviNet Inc:企業の戦略的SWOT分析
    NaviNet Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Thales SA:企業の戦略・SWOT・財務情報
    Thales SA - Strategy, SWOT and Corporate Finance Report Summary Thales SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Drax Group Plc (DRX)-エネルギー分野:企業M&A・提携分析
    Summary Drax Group plc (Drax) is a biomass-fuelled electricity generator, which generates electricity from coal and biomass. It operates across three principal areas of activity, electricity generation; electricity sales to business customers; and compressed wood pellet production. The company opera …
  • Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Mitsubishi Tanabe Pharma Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Tanabe Pharma Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Tanabe Pharma Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • SM Energy Co (SM):企業の財務・戦略的SWOT分析
    SM Energy Co (SM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sibanye Gold Ltd:戦略・SWOT・企業財務分析
    Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Berkem SA:企業の戦略・SWOT・財務情報
    Berkem SA - Strategy, SWOT and Corporate Finance Report Summary Berkem SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Petromin Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petromin Resources Ltd (Petromin) is an oil and gas exploration and production company that acquires, explores, develops and produces petroleum and natural gas. The company’s projects include Gilby, Redwater, Frog Lake and MorningSide projects in Alberta, Canada. It also explores and develop …
  • CDI Corp:企業の戦略的SWOT分析
    CDI Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Water Intelligence PLC (WATR):企業の財務・戦略的SWOT分析
    Summary Water Intelligence plc (Water Intelligence) formerly Qonnectis Plc, is a clean technology company that offers environmental and technology services. The company offers services such as finding, detecting, and remediating water leaks services. It monitors and protects water infrastructure and …
  • Dow Silicones Corp:企業の戦略的SWOT分析
    Dow Silicones Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • DTE Energy Co (DTE)-エネルギー分野:企業M&A・提携分析
    Summary DTE Energy Company (DTE Energy) is a diversified energy company that develops and manages energy-related businesses and services. It has presence in the electricity value chain from generation, procurement, to transmission, distribution, and sales. The company procures, stores, and transport …
  • Codexis Inc (CDXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Codexis Inc (Codexis) is a protein engineering company, which develops proteins for a wide range of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, industrial enzymes and fine chemicals, and enzymes as biotherapeutics and for use in molecular diagno …
  • Precipio Inc (TBIO):医療機器:M&Aディール及び事業提携情報
    Summary Precipio Inc (Precipio), formerly Transgenomic Inc, is a developer and provider of diagnostic tools and services. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services …
  • TreeHouse Foods, Inc.:企業の戦略・SWOT・財務情報
    TreeHouse Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary TreeHouse Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆